PegBio Co., Ltd. (HKG:2565)
Hong Kong
· Delayed Price · Currency is HKD 10.94
+0.36 (3.40%)
Last updated: May 29, 2025
PegBio Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Net Income | -283.16 | -279 | -130.35 | -206.79 | -91.39 |
| Depreciation & Amortization | 2.2 | 3.44 | 0.93 | 1.07 | 0.6 |
| Other Amortization | 0.3 | 0.31 | 1.25 | 1.25 | 0.41 |
| Loss (Gain) From Sale of Assets | 0.07 | -0.69 | - | - | - |
| Asset Writedown & Restructuring Costs | - | - | 4.76 | 0.02 | 0.05 |
| Loss (Gain) From Sale of Investments | -6.01 | -6.33 | -0.68 | -0.99 | -1 |
| Stock-Based Compensation | 145.47 | 35.11 | - | - | - |
| Provision & Write-off of Bad Debts | - | -0.06 | 0.09 | 0.04 | - |
| Other Operating Activities | 2.31 | 1.55 | 1.99 | -1.42 | -2.76 |
| Change in Accounts Receivable | - | - | -24.11 | -2.07 | 1.15 |
| Change in Inventory | - | - | 1.37 | -1.7 | -1.38 |
| Change in Accounts Payable | -33.29 | 20.16 | -43.83 | 86.57 | 32.84 |
| Change in Unearned Revenue | -3 | -0.13 | - | - | - |
| Change in Other Net Operating Assets | -8.32 | -7.65 | - | 55.59 | - |
| Operating Cash Flow | -183.44 | -233.28 | -188.59 | -68.43 | -61.47 |
| Capital Expenditures | -0.88 | -0.62 | -0.53 | -0.61 | -8.02 |
| Sale (Purchase) of Intangibles | -0.21 | 25.49 | - | - | - |
| Investment in Securities | 115.44 | 76.75 | -61.2 | 2.9 | -6.17 |
| Other Investing Activities | - | - | -5.84 | 0.99 | 1 |
| Investing Cash Flow | 114.35 | 101.62 | -67.58 | 3.27 | -13.19 |
| Short-Term Debt Issued | 91.51 | 50 | 140 | 40 | 25 |
| Total Debt Issued | 91.51 | 50 | 140 | 40 | 25 |
| Short-Term Debt Repaid | -65.96 | -31.71 | -65 | -30 | -9 |
| Long-Term Debt Repaid | -1.29 | -2.06 | - | - | - |
| Total Debt Repaid | -67.24 | -33.77 | -65 | -30 | -9 |
| Net Debt Issued (Repaid) | 24.27 | 16.23 | 75 | 10 | 16 |
| Issuance of Common Stock | - | 133.8 | 918.49 | 70.22 | 54.51 |
| Common Dividends Paid | - | - | -3.06 | -1.5 | -0.37 |
| Other Financing Activities | -3.93 | -1.52 | -1 | - | - |
| Financing Cash Flow | 20.33 | 148.51 | 989.42 | 78.72 | 70.14 |
| Foreign Exchange Rate Adjustments | - | 0 | -0.43 | 0.37 | 1.56 |
| Net Cash Flow | -48.76 | 16.85 | 732.83 | 13.93 | -2.96 |
| Free Cash Flow | -184.32 | -233.9 | -189.12 | -69.04 | -69.49 |
| Free Cash Flow Margin | - | - | - | -28482.33% | -63842.09% |
| Free Cash Flow Per Share | -0.50 | -0.65 | -0.71 | - | - |
| Cash Interest Paid | 2.25 | 1.52 | - | - | - |
| Cash Income Tax Paid | - | - | -2.5 | -1.36 | 0.02 |
| Levered Free Cash Flow | -78.82 | - | -214.33 | -59.2 | - |
| Unlevered Free Cash Flow | -77.25 | - | -212.37 | -58.25 | - |
| Change in Net Working Capital | 44.39 | - | 130.98 | -75.95 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.